A detailed history of Waycross Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Waycross Partners, LLC holds 134,470 shares of EW stock, worth $12.3 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares
134,470
Previous 123,321 9.04%
Holding current value
$12.3 Million
Previous $9.4 Million 36.65%
% of portfolio
2.21%
Previous 1.76%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$72.54 - $95.56 $808,748 - $1.07 Million
11,149 Added 9.04%
134,470 $12.8 Million
Q4 2023

Feb 05, 2024

SELL
$61.71 - $77.76 $459,554 - $579,078
-7,447 Reduced 5.69%
123,321 $9.4 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $473,390 - $638,065
6,833 Added 5.51%
130,768 $9.06 Million
Q2 2023

Jul 26, 2023

BUY
$81.41 - $94.33 $2.21 Million - $2.56 Million
27,144 Added 28.04%
123,935 $11.7 Million
Q1 2023

May 04, 2023

BUY
$74.26 - $84.51 $1.27 Million - $1.44 Million
17,035 Added 21.36%
96,791 $8.01 Million
Q4 2022

Feb 06, 2023

BUY
$68.3 - $87.44 $5.45 Million - $6.97 Million
79,756 New
79,756 $5.95 Million
Q3 2021

Nov 10, 2021

SELL
$102.91 - $122.75 $3.64 Million - $4.34 Million
-35,366 Closed
0 $0
Q2 2021

Aug 17, 2021

BUY
$83.84 - $104.76 $1.47 Million - $1.83 Million
17,513 Added 98.1%
35,366 $3.66 Million
Q2 2021

Aug 13, 2021

SELL
$83.84 - $104.76 $1.62 Million - $2.02 Million
-19,298 Reduced 51.94%
17,853 $285 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $287,890 - $331,761
-3,659 Reduced 8.97%
37,151 $3.11 Million
Q4 2020

Feb 08, 2021

BUY
$71.69 - $91.23 $2.93 Million - $3.72 Million
40,810 New
40,810 $3.72 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Waycross Partners, LLC Portfolio

Follow Waycross Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waycross Partners, LLC with notifications on news.